Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Deykin

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Allergy and Clinical Immunology|September 5, 2006
Biomarker-driven care in asthma: are we there?Aaron Deykin
The New England Journal of Medicine|March 1, 2005
Prostanoid DP receptor variants and asthmaAaron Deykin
The New England Journal of Medicine|May 26, 2005
Targeting biologic markers in asthma--is exhaled nitric oxide the bull's-eye?Aaron Deykin
Clinics in Chest Medicine|May 1, 2007
Advances in lung transplantation for patients who have cystic fibrosisHilary J Goldberg, Aaron Deykin
American Journal of Respiratory and Critical Care Medicine|June 19, 2002
Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rateAaron Deykin, Anthony F Massaro, Jeffrey M Drazen, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 15, 2016
Analysis of peginterferon β-1a exposure and Gd-enhanced lesion or T2 lesion response in relapsing-remitting multiple sclerosis patientsYaming Hang, Xiao Hu, Jie Zhang, et al.
Current Medical Research and Opinion|October 13, 2011
Dose titration of intramuscular interferon beta-1a reduces the severity and incidence of flu-like symptoms during treatment initiationMark A Matson, Thomas R Zimmerman, Dianne Tuccillo, et al.
BMC Neurology|October 18, 2011
An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjectsJ Theodore Phillips, Edward Fox, William Grainger, et al.
British Journal of Clinical Pharmacology|September 30, 2014
Pharmacokinetics and pharmacodynamics of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis in the randomized ADVANCE studyXiao Hu, Yue Cui, Joleen White, et al.
Journal of Clinical Pharmacology|April 11, 2017
Population-Based Pharmacokinetic and Exposure-Efficacy Analyses of Peginterferon Beta-1a in Patients With Relapsing Multiple SclerosisXiao Hu, Yaming Hang, Yue Cui, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Allergy and Clinical Immunology|September 5, 2006
Biomarker-driven care in asthma: are we there?Aaron Deykin
The New England Journal of Medicine|March 1, 2005
Prostanoid DP receptor variants and asthmaAaron Deykin
The New England Journal of Medicine|May 26, 2005
Targeting biologic markers in asthma--is exhaled nitric oxide the bull's-eye?Aaron Deykin
Clinics in Chest Medicine|May 1, 2007
Advances in lung transplantation for patients who have cystic fibrosisHilary J Goldberg, Aaron Deykin
American Journal of Respiratory and Critical Care Medicine|June 19, 2002
Exhaled nitric oxide as a diagnostic test for asthma: online versus offline techniques and effect of flow rateAaron Deykin, Anthony F Massaro, Jeffrey M Drazen, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 15, 2016
Analysis of peginterferon β-1a exposure and Gd-enhanced lesion or T2 lesion response in relapsing-remitting multiple sclerosis patientsYaming Hang, Xiao Hu, Jie Zhang, et al.
Current Medical Research and Opinion|October 13, 2011
Dose titration of intramuscular interferon beta-1a reduces the severity and incidence of flu-like symptoms during treatment initiationMark A Matson, Thomas R Zimmerman, Dianne Tuccillo, et al.
BMC Neurology|October 18, 2011
An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex® prefilled syringe in multiple sclerosis subjectsJ Theodore Phillips, Edward Fox, William Grainger, et al.
British Journal of Clinical Pharmacology|September 30, 2014
Pharmacokinetics and pharmacodynamics of peginterferon beta-1a in patients with relapsing-remitting multiple sclerosis in the randomized ADVANCE studyXiao Hu, Yue Cui, Joleen White, et al.
Journal of Clinical Pharmacology|April 11, 2017
Population-Based Pharmacokinetic and Exposure-Efficacy Analyses of Peginterferon Beta-1a in Patients With Relapsing Multiple SclerosisXiao Hu, Yaming Hang, Yue Cui, et al.
Pageof 4